BiotechTube
Home/Poxel/Cécile Baudrier
CB

Cécile Baudrier

Chief Financial Officer

Poxel

Therapeutic Areas

Non-alcoholic Steatohepatitis (NASH)Rare Metabolic DisordersType 2 Diabetes

Poxel Pipeline

DrugIndicationPhase
PXL065Non-alcoholic steatohepatitis (NASH)Phase 2
PXL770Rare Metabolic Diseases (e.g., ADPKD)Phase 2a
TWYMEEG (Imeglimin)Type 2 DiabetesMarketed

Leadership Team at Poxel

TK
Thomas Kuhn
Chief Executive Officer
SB
Sébastien Bolze
Founder and Chairman of the Board
DS
David S. Horn
Chief Medical Officer
View full Poxel profile